Vulnerabilities

Vulnerability · CVE-2019-25724

Dräger Infinity M300 patient worn monitors with software version VG2.x and earlier contain a network-based denial of service vulnerability that allows attackers with a…

Published Jun 2, 2026 · catalog updated Jul 22, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2019-25724. EPSS is 0.18%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.18%
Remediation
Advisory link
Affected products
See sources for product scope

Dräger Infinity M300 patient worn monitors with software version VG2.x and earlier contain a network-based denial of service vulnerability that allows attackers with access to the hospital or Infinity Network to repeatedly trigger device reboots until the device enters a fail state requiring manual restart. Attackers can exploit this vulnerability to cause loss of wireless network connectivity, temporary loss of patient monitoring, and interruption of alarm functionality until the device is manually recovered.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2019-25724

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2019-25724. EPSS is 0.18%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-400: Uncontrolled Resource Consumption. EPSS 0.18%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 2, 2026 · NIST NVD

    Detected

    Dräger Infinity M300 patient worn monitors with software version VG2.x and earlier contain a network-based denial of service vulnerability that allows attackers with access to the hospital or Infinity Network to repeatedly trigger device reboots until the device enters a fail state requiring manual restart. Attackers can exploit this vulnerability to cause loss of wireless network connectivity, te

  2. Jul 22, 2026 · NIST NVD

    Updated

    Dräger Infinity M300 patient worn monitors with software version VG2.x and earlier contain a network-based denial of service vulnerability that allows attackers with access to the hospital or Infinity Network to repeatedly trigger device reboots until the device enters a fail state requiring manual restart. Attackers can exploit this vulnerability to cause loss of wireless network connectivity, te

Sources

  • CVE.orgVulnerability recordCVE-2019-25724

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2019-25724

    30-day exploitation probability 0.18%

    first.org
  • NIST NVDVulnerability recordCVE-2019-25724

    Dräger Infinity M300 patient worn monitors with software version VG2.x and earlier contain a network-based denial of service vulnerability that allows attackers with access to the hospital or Infinity Network to repeatedly trigger device reboots until the device enters a fail sta

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 24, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.